{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:25:26Z","timestamp":1793755526342,"version":"4.6.1"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"DOI":"10.7759\/cureus.95302","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:03:48Z","timestamp":1761303828000},"source":"Crossref","is-referenced-by-count":7,"title":["Knee Osteoarthritis: Current Insights Into Pathophysiology and Non-surgical Management Options"],"prefix":"10.7759","author":[{"given":"Mohammed","family":"Elmajee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mersal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Ben Nafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Embaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elbioumy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elmahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Embabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis","volume":"26","author":"Zhang Y","year":"2010","unstructured":"Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010, 26:355-69. 10.1016\/j.cger.2010.03.001","journal-title":"Clin Geriatr Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.44","article-title":"The individual and socioeconomic impact of osteoarthritis","volume":"10","author":"Hunter DJ","year":"2014","unstructured":"Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014, 10:437-41. 10.1038\/nrrheum.2014.44","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2005.09.007","article-title":"Osteoarthritis: epidemiology","volume":"20","author":"Arden N","year":"2006","unstructured":"Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006, 20:3-25. 10.1016\/j.berh.2005.09.007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref4","unstructured":"National population projections. 2018-based. (2019). Accessed: October 11, 2025: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationprojections\/bulletins\/nationalpo...."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.NAJ.0000412646.80054.21","article-title":"The impact of osteoarthritis in the United States: a population-health perspective","volume":"112","author":"Murphy L","year":"2012","unstructured":"Murphy L, Helmick CG. The impact of osteoarthritis in the United States: a population-health perspective. Am J Nurs. 2012, 112:S13-19. 10.1097\/01.NAJ.0000412646.80054.21","journal-title":"Am J Nurs"},{"key":"ref6","article-title":"Arthritis Research UK: Osteoarthritis in General Practice","author":"Arthritis Research UK","year":"2013","unstructured":"Arthritis Research UK. Osteoarthritis in General Practice. Arthritis Research UK, Chesterfield; 2013. https:\/\/www.versusarthritis.org\/media\/2115\/osteoarthritis-in-general-practice.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204763","article-title":"The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross M","year":"2014","unstructured":"Cross M, Smith E, Hoy D, et al.. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014, 73:1323-30. 10.1136\/annrheumdis-2013-204763","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.135","article-title":"Strategies for the prevention of knee osteoarthritis","volume":"12","author":"Roos EM","year":"2016","unstructured":"Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol. 2016, 12:92-101. 10.1038\/nrrheum.2015.135","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/genes11080854","article-title":"Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations","volume":"11","author":"Primorac D","year":"2020","unstructured":"Primorac D, Molnar V, Rod E, et al.. Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations. Genes (Basel). 2020, 11:854. 10.3390\/genes11080854","journal-title":"Genes (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-014-9917-9","article-title":"Osteoarthritis pathogenesis: a review of molecular mechanisms","volume":"95","author":"Xia B","year":"2014","unstructured":"Xia B, Di Chen, Zhang J, Hu S, Jin H, Tong P. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014, 95:495-505. 10.1007\/s00223-014-9917-9","journal-title":"Calcif Tissue Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.148","article-title":"Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk","volume":"12","author":"Goldring SR","year":"2016","unstructured":"Goldring SR, Goldring MB. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 2016, 12:632-44. 10.1038\/nrrheum.2016.148","journal-title":"Nat Rev Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.csm.2017.02.001","article-title":"Basic Science of Articular Cartilage","volume":"36","author":"Carballo CB","year":"2017","unstructured":"Carballo CB, Nakagawa Y, Sekiya I, Rodeo SA. Basic Science of Articular Cartilage. Clin Sports Med. 2017, 36:413-25. 10.1016\/j.csm.2017.02.001","journal-title":"Clin Sports Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0945-053x(94)90195-3","article-title":"Molecular basis of nanomelia, a heritable chondrodystrophy of chicken","volume":"14","author":"Primorac D","year":"1994","unstructured":"Primorac D, Stover ML, Clark SH, Rowe DW. Molecular basis of nanomelia, a heritable chondrodystrophy of chicken. Matrix Biology. 1994, 14:297-305. 10.1016\/0945-053x(94)90195-3","journal-title":"Matrix Biology"},{"key":"ref14","article-title":"Reduced type II collagen mRNA in nanomelic cultured chondrocytes: an example of extracellular matrix\/collagen feedback regulation?","volume":"36","author":"Primorac D","year":"1995","unstructured":"Primorac D. Reduced type II collagen mRNA in nanomelic cultured chondrocytes: an example of extracellular matrix\/collagen feedback regulation?. Croat Med J. 1995, 36:85-92.","journal-title":"Croat Med J"},{"key":"ref15","article-title":"Premature termination codon in the aggrecan gene of nanomelia and its influence on mRNA transport and stability","volume":"40","author":"Primorac D","year":"1999","unstructured":"Primorac D, Johnson CV, Lawrence JB, et al.. Premature termination codon in the aggrecan gene of nanomelia and its influence on mRNA transport and stability. Croat Med J. 1999, 40:528-32.","journal-title":"Croat Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0375-6","article-title":"Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis","volume":"15","author":"Houard X","year":"2013","unstructured":"Houard X, Goldring MB, Berenbaum F. Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep. 2013, 15:375. 10.1007\/s11926-013-0375-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/ar2592","article-title":"Cartilage homeostasis in health and rheumatic diseases","volume":"11","author":"Goldring MB","year":"2009","unstructured":"Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther. 2009, 11:224. 10.1186\/ar2592","journal-title":"Arthritis Res Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1201\/9781135042653","article-title":"Introduction to Cell Mechanics and Mechanobiology","author":"Jacobs CR","year":"2012","unstructured":"Jacobs CR, Huang H, Kwon RY. Introduction to Cell Mechanics and Mechanobiology. Garland Science, New York; 2012. 10.1201\/9781135042653"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jfmk1020154","article-title":"The effect of mechanical loading on articular cartilage","volume":"1","author":"Musumeci G","year":"2016","unstructured":"Musumeci G. The effect of mechanical loading on articular cartilage. J Funct Morphol Kinesiol. 2016, 1:154-61. 10.3390\/jfmk1020154","journal-title":"J Funct Morphol Kinesiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/art.11367","article-title":"Longitudinal analysis of cartilage atrophy in the knees of patients with spinal cord injury","volume":"48","author":"Vanwanseele B","year":"2003","unstructured":"Vanwanseele B, Eckstein F, Knecht H, Spaepen A, St\u00fcssi E. Longitudinal analysis of cartilage atrophy in the knees of patients with spinal cord injury. Arthritis Rheum. 2003, 48:3377-81. 10.1002\/art.11367","journal-title":"Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/ar4405","article-title":"Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes","volume":"15","author":"Li G","year":"2013","unstructured":"Li G, Yin J, Gao J, Cheng TS, Pavlos NJ, Zhang C, Zheng MH. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther. 2013, 15:223. 10.1186\/ar4405","journal-title":"Arthritis Res Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/art.33445","article-title":"Regulation of subchondral bone osteoblast metabolism by cyclic compression","volume":"64","author":"Sanchez C","year":"2012","unstructured":"Sanchez C, Pesesse L, Gabay O, Delcour JP, Msika P, Baudouin C, Henrotin YE. Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis Rheum. 2012, 64:1193-203. 10.1002\/art.33445","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2008.09.006","article-title":"Role of bone in osteoarthritis pathogenesis","volume":"93","author":"Goldring SR","year":"2009","unstructured":"Goldring SR. Role of bone in osteoarthritis pathogenesis. Med Clin North Am. 2009, 93:25-35. 10.1016\/j.mcna.2008.09.006","journal-title":"Med Clin North Am"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2019.03.004","article-title":"Clinical implications of macrophage dysfunction in the development of osteoarthritis of the knee","volume":"46","author":"Xie J","year":"2019","unstructured":"Xie J, Huang Z, Yu X, Zhou L, Pei F. Clinical implications of macrophage dysfunction in the development of osteoarthritis of the knee. Cytokine Growth Factor Rev. 2019, 46:36-44. 10.1016\/j.cytogfr.2019.03.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6390182","article-title":"Contribution of infrapatellar fat pad and synovial membrane to knee osteoarthritis pain","volume":"2019","author":"Belluzzi E","year":"2019","unstructured":"Belluzzi E, Stocco E, Pozzuoli A, et al.. Contribution of infrapatellar fat pad and synovial membrane to knee osteoarthritis pain. Biomed Res Int. 2019, 2019:6390182. 10.1155\/2019\/6390182","journal-title":"Biomed Res Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/joa.13177","article-title":"An investigation of the anatomy of the infrapatellar fat pad and its possible involvement in anterior pain syndrome: a cadaveric study","volume":"237","author":"Leese J","year":"2020","unstructured":"Leese J, Davies DC. An investigation of the anatomy of the infrapatellar fat pad and its possible involvement in anterior pain syndrome: a cadaveric study. J Anat. 2020, 237:20-8. 10.1111\/joa.13177","journal-title":"J Anat"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2017_77","article-title":"Hoffa\u2019s fat pad abnormality in the development of knee osteoarthritis","volume":"1039","author":"Paduszy\u0144ski W","year":"2018","unstructured":"Paduszy\u0144ski W, Je\u015bkiewicz M, Ucha\u0144ski P, Gackowski S, Radkowski M, Demkow U. Hoffa\u2019s fat pad abnormality in the development of knee osteoarthritis. Adv Exp Med Biol. 2018, 1039:95-102. 10.1007\/5584_2017_77","journal-title":"Adv Exp Med Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/art.40056","article-title":"Profibrotic infrapatellar fat pad remodeling without M1 macrophage polarization precedes knee osteoarthritis in mice with diet-induced obesity","volume":"69","author":"Barboza E","year":"2017","unstructured":"Barboza E, Hudson J, Chang WP, et al.. Profibrotic infrapatellar fat pad remodeling without M1 macrophage polarization precedes knee osteoarthritis in mice with diet-induced obesity. Arthritis Rheumatol. 2017, 69:1221-32. 10.1002\/art.40056","journal-title":"Arthritis Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.01.018","article-title":"Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism","volume":"15","author":"Simopoulou T","year":"2007","unstructured":"Simopoulou T, Malizos KN, Iliopoulos D, Stefanou N, Papatheodorou L, Ioannou M, Tsezou A. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage. 2007, 15:872-83. 10.1016\/j.joca.2007.01.018","journal-title":"Osteoarthritis Cartilage"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21258","article-title":"Osteoarthritis","volume":"213","author":"Goldring MB","year":"2007","unstructured":"Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007, 213:626-34. 10.1002\/jcp.21258","journal-title":"J Cell Physiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz P","year":"2014","unstructured":"Wojdasiewicz P, Poniatowski \u0141A, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014, 2014:561459. 10.1155\/2014\/561459","journal-title":"Mediators Inflamm"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000804","article-title":"Serum inflammatory markers in patients with knee osteoarthritis: a proteomic approach","volume":"36","author":"Giordano R","year":"2020","unstructured":"Giordano R, Petersen KK, Andersen HH, Simonsen O, Arendt-Nielsen L. Serum inflammatory markers in patients with knee osteoarthritis: a proteomic approach. Clin J Pain. 2020, 36:229-37. 10.1097\/AJP.0000000000000804","journal-title":"Clin J Pain"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091343","article-title":"Synovial cytokines significantly correlate with osteoarthritis-related knee pain and disability: inflammatory mediators of potential clinical relevance","volume":"8","author":"Nees TA","year":"2019","unstructured":"Nees TA, Rosshirt N, Zhang JA, et al.. Synovial cytokines significantly correlate with osteoarthritis-related knee pain and disability: inflammatory mediators of potential clinical relevance. J Clin Med. 2019, 8:1343. 10.3390\/jcm8091343","journal-title":"J Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101631","article-title":"Divergent mononuclear cell participation and cytokine release profiles define hip and knee osteoarthritis","volume":"8","author":"Grieshaber-Bouyer R","year":"2019","unstructured":"Grieshaber-Bouyer R, K\u00e4mmerer T, Rosshirt N, et al.. Divergent mononuclear cell participation and cytokine release profiles define hip and knee osteoarthritis. J Clin Med. 2019, 8:1631. 10.3390\/jcm8101631","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-018-1955-4","article-title":"Serum and synovial fluid cytokine profiling in hip osteoarthritis: distinct from knee osteoarthritis and correlated with pain","volume":"19","author":"Ren G","year":"2018","unstructured":"Ren G, Lutz I, Railton P, Wiley JP, McAllister J, Powell J, Krawetz RJ. Serum and synovial fluid cytokine profiling in hip osteoarthritis: distinct from knee osteoarthritis and correlated with pain. BMC Musculoskelet Disord. 2018, 19:39. 10.1186\/s12891-018-1955-4","journal-title":"BMC Musculoskelet Disord"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher M","year":"2019","unstructured":"Bl\u00fcher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019, 15:288-98. 10.1038\/s41574-019-0176-8","journal-title":"Nat Rev Endocrinol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/art.24021","article-title":"Lifetime risk of symptomatic knee osteoarthritis","volume":"59","author":"Murphy L","year":"2008","unstructured":"Murphy L, Schwartz TA, Helmick CG, et al.. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008, 59:1207-13. 10.1002\/art.24021","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-019-03127-5","article-title":"The outcomes of total knee arthroplasty in morbidly obese patients: a systematic review of the literature","volume":"139","author":"Boyce L","year":"2019","unstructured":"Boyce L, Prasad A, Barrett M, Dawson-Bowling S, Millington S, Hanna SA, Achan P. The outcomes of total knee arthroplasty in morbidly obese patients: a systematic review of the literature. Arch Orthop Trauma Surg. 2019, 139:553-60. 10.1007\/s00402-019-03127-5","journal-title":"Arch Orthop Trauma Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2004.011841","article-title":"Obesity: a preventable risk factor for large joint osteoarthritis which may act through biomechanical factors","volume":"39","author":"Powell A","year":"2005","unstructured":"Powell A, Teichtahl AJ, Wluka AE, Cicuttini FM. Obesity: a preventable risk factor for large joint osteoarthritis which may act through biomechanical factors. Br J Sports Med. 2005, 39:4-5. 10.1136\/bjsm.2004.011841","journal-title":"Br J Sports Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.123","article-title":"Obesity punches above its weight in osteoarthritis","volume":"7","author":"Aspden RM","year":"2011","unstructured":"Aspden RM. Obesity punches above its weight in osteoarthritis. Nat Rev Rheumatol. 2011, 7:65-8. 10.1038\/nrrheum.2010.123","journal-title":"Nat Rev Rheumatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03759-w","article-title":"IL-6 secretion in osteoarthritis patients is mediated by chondrocyte-synovial fibroblast cross-talk and is enhanced by obesity","volume":"7","author":"Pearson MJ","year":"2017","unstructured":"Pearson MJ, Herndler-Brandstetter D, Tariq MA, et al.. IL-6 secretion in osteoarthritis patients is mediated by chondrocyte-synovial fibroblast cross-talk and is enhanced by obesity. Sci Rep. 2017, 7:3451. 10.1038\/s41598-017-03759-w","journal-title":"Sci Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2014.948914","article-title":"Adipokines as potential prognostic biomarkers in patients with acute knee injury","volume":"20","author":"Kluzek S","year":"2015","unstructured":"Kluzek S, Arden NK, Newton J. Adipokines as potential prognostic biomarkers in patients with acute knee injury. Biomarkers. 2015, 20:519-25. 10.3109\/1354750X.2014.948914","journal-title":"Biomarkers"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2019.11.010","article-title":"Osteoarthritis year in review 2019: genetics, genomics and epigenetics","volume":"28","author":"Reynard LN","year":"2020","unstructured":"Reynard LN, Barter MJ. Osteoarthritis year in review 2019: genetics, genomics and epigenetics. Osteoarthritis Cartilage. 2020, 28:275-84. 10.1016\/j.joca.2019.11.010","journal-title":"Osteoarthritis Cartilage"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040840","article-title":"Coordinated actions of microRNAs with other epigenetic factors regulate skeletal muscle development and adaptation","volume":"18","author":"Bianchi M","year":"2017","unstructured":"Bianchi M, Renzini A, Adamo S, Moresi V. Coordinated actions of microRNAs with other epigenetic factors regulate skeletal muscle development and adaptation. Int J Mol Sci. 2017, 18:840. 10.3390\/ijms18040840","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S53974","article-title":"The pain-relieving qualities of exercise in knee osteoarthritis","volume":"5","author":"Susko AM","year":"2013","unstructured":"Susko AM, Fitzgerald GK. The pain-relieving qualities of exercise in knee osteoarthritis. Open Access Rheumatol. 2013, 5:81-91. 10.2147\/OARRR.S53974","journal-title":"Open Access Rheumatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001923","article-title":"Peripheral pain mechanisms in osteoarthritis","volume":"161","author":"Vincent TL","year":"2020","unstructured":"Vincent TL. Peripheral pain mechanisms in osteoarthritis. Pain. 2020, 161:S138-46. 10.1097\/j.pain.0000000000001923","journal-title":"Pain"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.80","article-title":"Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis","volume":"8","author":"Mapp PI","year":"2012","unstructured":"Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol. 2012, 8:390-8. 10.1038\/nrrheum.2012.80","journal-title":"Nat Rev Rheumatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225041","article-title":"EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update","volume":"83","author":"Moseng T","year":"2024","unstructured":"Moseng T, Vliet Vlieland TP, Battista S, et al.. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Ann Rheum Dis. 2024, 83:730-40. 10.1136\/ard-2023-225041","journal-title":"Ann Rheum Dis"},{"key":"ref49","unstructured":"Osteoarthritis in over 16s. diagnosis and management. (2022). Accessed: October 11, 2025: https:\/\/www.nice.org.uk\/guidance\/ng226."},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2011.01612.x","article-title":"Physiotherapy management of knee osteoarthritis","volume":"14","author":"Page CJ","year":"2011","unstructured":"Page CJ, Hinman RS, Bennell KL. Physiotherapy management of knee osteoarthritis. Int J Rheum Dis. 2011, 14:145-51. 10.1111\/j.1756-185X.2011.01612.x","journal-title":"Int J Rheum Dis"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.854026","article-title":"Exercise for osteoarthritis: a literature review of Pathology and mechanism","volume":"14","author":"Kong H","year":"2022","unstructured":"Kong H, Wang XQ, Zhang XA. Exercise for osteoarthritis: a literature review of Pathology and mechanism. Front Aging Neurosci. 2022, 14:854026. 10.3389\/fnagi.2022.854026","journal-title":"Front Aging Neurosci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2016.02.004","article-title":"Exercise-driven metabolic pathways in healthy cartilage","volume":"24","author":"Blazek AD","year":"2016","unstructured":"Blazek AD, Nam J, Gupta R, et al.. Exercise-driven metabolic pathways in healthy cartilage. Osteoarthritis Cartilage. 2016, 24:1210-22. 10.1016\/j.joca.2016.02.004","journal-title":"Osteoarthritis Cartilage"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6196398","article-title":"Moderate mechanical stimulation protects rats against osteoarthritis through the regulation of TRAIL via the NF-\u03bab\/NLRP3 pathway","volume":"2020","author":"Yang Y","year":"2020","unstructured":"Yang Y, Wang Y, Kong Y, et al.. Moderate mechanical stimulation protects rats against osteoarthritis through the regulation of TRAIL via the NF-\u03bab\/NLRP3 pathway. Oxid Med Cell Longev. 2020, 2020:6196398. 10.1155\/2020\/6196398","journal-title":"Oxid Med Cell Longev"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.12.014","article-title":"Treadmill and wheel exercise protect against JNK\/NF-\u03baB induced inflammation in experimental models of knee osteoarthritis","volume":"523","author":"Chen L","year":"2020","unstructured":"Chen L, Lou Y, Pan Z, Cao X, Zhang L, Zhu C, Liang J. Treadmill and wheel exercise protect against JNK\/NF-\u03baB induced inflammation in experimental models of knee osteoarthritis. Biochem Biophys Res Commun. 2020, 523:117-22. 10.1016\/j.bbrc.2019.12.014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.794062","article-title":"Benefits and mechanisms of exercise training for knee osteoarthritis","volume":"12","author":"Zeng CY","year":"2021","unstructured":"Zeng CY, Zhang ZR, Tang ZM, Hua FZ. Benefits and mechanisms of exercise training for knee osteoarthritis. Front Physiol. 2021, 12:794062. 10.3389\/fphys.2021.794062","journal-title":"Front Physiol"},{"key":"ref56","unstructured":"(2016). https.\/\/www.hopkinsarthritis.org\/patient-corner\/disease-management\/role-of-exercise-in-arthritis-management\/.."},{"key":"ref57","article-title":"Clinical Therapeutic Applications of the Kinesio Taping\u00ae Method","author":"Kase K","year":"2003","unstructured":"Kase K, Wallis J, Kase T. Clinical Therapeutic Applications of the Kinesio Taping\u00ae Method. Kinesio Taping Association, Dallas (ed): 2003."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.explore.2020.08.001","article-title":"Does current evidence support the use of kinesiology taping in people with knee osteoarthritis?","volume":"17","author":"Pinheiro YT","year":"2021","unstructured":"Pinheiro YT, E Silva RL, de Almeida Silva HJ, de Ara\u00fajo TA, da Silva RS, de Souza MC, de Almeida Lins CA. Does current evidence support the use of kinesiology taping in people with knee osteoarthritis?. Explore (NY). 2021, 17:574-7. 10.1016\/j.explore.2020.08.001","journal-title":"Explore (NY)"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S249567","article-title":"Effectiveness of Kinesio Taping on the Management of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials","volume":"13","author":"Melese H","year":"2020","unstructured":"Melese H, Alamer A, Hailu Temesgen M, Nigussie F. Effectiveness of Kinesio Taping on the Management of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials. J Pain Res. 2020, 13:1267-76. 10.2147\/JPR.S249567","journal-title":"J Pain Res"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2006.02.099","article-title":"Evaluation of off-loading braces for treatment of unicompartmental knee arthrosis","volume":"21","author":"Dennis DA","year":"2006","unstructured":"Dennis DA, Komistek RD, Nadaud MC, Mahfouz M. Evaluation of off-loading braces for treatment of unicompartmental knee arthrosis. J Arthroplasty. 2006, 21:2-8. 10.1016\/j.arth.2006.02.099","journal-title":"J Arthroplasty"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.F.01136","article-title":"A mechanical theory for the effectiveness of bracing for medial compartment osteoarthritis of the knee","volume":"89","author":"Ramsey DK","year":"2007","unstructured":"Ramsey DK, Briem K, Axe MJ, Snyder-Mackler L. A mechanical theory for the effectiveness of bracing for medial compartment osteoarthritis of the knee. J Bone Joint Surg Am. 2007, 89:2398-407. 10.2106\/JBJS.F.01136","journal-title":"J Bone Joint Surg Am"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24634","article-title":"Three-month efficacy of three knee braces in the treatment of medial knee osteoarthritis in a randomized crossover trial","volume":"38","author":"Robert-Lachaine X","year":"2020","unstructured":"Robert-Lachaine X, Dessery Y, Belzile \u00c9L, Turmel S, Corbeil P. Three-month efficacy of three knee braces in the treatment of medial knee osteoarthritis in a randomized crossover trial. J Orthop Res. 2020, 38:2262-71. 10.1002\/jor.24634","journal-title":"J Orthop Res"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/msc.70021","article-title":"Physiotherapists\u2019 experiences and perceived acceptability of delivering a knee bracing intervention for people with symptomatic knee osteoarthritis in a randomised trial (prop OA): a qualitative study","volume":"22","author":"Bullock L","year":"2024","unstructured":"Bullock L, Holden MA, Jinks C, et al.. Physiotherapists\u2019 experiences and perceived acceptability of delivering a knee bracing intervention for people with symptomatic knee osteoarthritis in a randomised trial (prop OA): a qualitative study. Musculoskeletal Care. 2024, 22:e70021. 10.1002\/msc.70021","journal-title":"Musculoskeletal Care"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/10400435.2021.1880495","article-title":"Effect of knee braces and insoles on clinical outcomes of individuals with medial knee osteoarthritis: a systematic review and meta-analysis","volume":"34","author":"Khosravi M","year":"2022","unstructured":"Khosravi M, Babaee T, Daryabor A, Jalali M. Effect of knee braces and insoles on clinical outcomes of individuals with medial knee osteoarthritis: a systematic review and meta-analysis. Assist Technol. 2022, 34:501-17. 10.1080\/10400435.2021.1880495","journal-title":"Assist Technol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-2836","article-title":"Effects of orthopedic insoles on patients with knee osteoarthritis: a meta-analysis and systematic review","volume":"53","author":"Yu L","year":"2021","unstructured":"Yu L, Wang Y, Yang J, Wang J, Zhang Y. Effects of orthopedic insoles on patients with knee osteoarthritis: a meta-analysis and systematic review. J Rehabil Med. 2021, 53:jrm00191. 10.2340\/16501977-2836","journal-title":"J Rehabil Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1002\/art.41142","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee","volume":"72","author":"Kolasinski SL","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, et al.. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020, 72:220-33. 10.1002\/art.41142","journal-title":"Arthritis Rheumatol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer260","article-title":"Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch","volume":"107","author":"Anand P","year":"2011","unstructured":"Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011, 107:490-502. 10.1093\/bja\/aer260","journal-title":"Br J Anaesth"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.10.053","article-title":"Mechanisms and clinical uses of capsaicin","volume":"720","author":"Sharma SK","year":"2013","unstructured":"Sharma SK, Vij AS, Sharma M. Mechanisms and clinical uses of capsaicin. Eur J Pharmacol. 2013, 720:55-62. 10.1016\/j.ejphar.2013.10.053","journal-title":"Eur J Pharmacol"},{"key":"ref69","unstructured":"Management of Osteoarthritis of the Knee (Non-Arthroplasty). Evidence-Based Clinical Practice Guideline. (2021). Accessed: October 11, 2025: https:\/\/www.aaos.org\/globalassets\/quality-and-practice-resources\/osteoarthritis-of-the-knee\/oak3cpg.pdf."},{"key":"ref70","article-title":"Comparison of tissue and plasma levels of ibuprofen after oral and topical administration","volume":"46","author":"Dominkus M","year":"1996","unstructured":"Dominkus M, Nicolakis M, Kotz R, Wilkinson FE, Kaiser RR, Chlud K. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittelforschung. 1996, 46:1138-43.","journal-title":"Arzneimittelforschung"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090935","article-title":"Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review","volume":"37","author":"Makris UE","year":"2010","unstructured":"Makris UE, Kohler MJ, Fraenkel L. Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol. 2010, 37:1236-43. 10.3899\/jrheum.090935","journal-title":"J Rheumatol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association","volume":"115","author":"Antman EM","year":"2007","unstructured":"Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007, 115:1634-42. 10.1161\/CIRCULATIONAHA.106.181424","journal-title":"Circulation"},{"key":"ref73","article-title":"A review of nonsteroidal anti-inflammatory drugs","volume":"83","author":"Bozimowski G","year":"2015","unstructured":"Bozimowski G. A review of nonsteroidal anti-inflammatory drugs. AANA J. 2015, 83:425-33.","journal-title":"AANA J"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2017.06.006","article-title":"Topical treatment of degenerative knee osteoarthritis","volume":"355","author":"Meng Z","year":"2018","unstructured":"Meng Z, Huang R. Topical treatment of degenerative knee osteoarthritis. Am J Med Sci. 2018, 355:6-12. 10.1016\/j.amjms.2017.06.006","journal-title":"Am J Med Sci"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2022.11.005","article-title":"Pharmaceutical treatment of osteoarthritis","volume":"31","author":"Richard MJ","year":"2023","unstructured":"Richard MJ, Driban JB, McAlindon TE. Pharmaceutical treatment of osteoarthritis. Osteoarthritis Cartilage. 2023, 31:458-66. 10.1016\/j.joca.2022.11.005","journal-title":"Osteoarthritis Cartilage"},{"key":"ref76","article-title":"Paracetamol: mechanism of action, applications and safety concern","volume":"71","author":"J\u00f3\u017awiak-Bebenista M","year":"2014","unstructured":"J\u00f3\u017awiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014, 71:11-23.","journal-title":"Acta Pol Pharm"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00623-5","article-title":"Revisiting Tramadol: A Multi-Modal Agent for Pain Management","volume":"33","author":"Barakat A","year":"2019","unstructured":"Barakat A. Revisiting Tramadol: A Multi-Modal Agent for Pain Management. CNS Drugs. 2019, 33:481-501. 10.1007\/s40263-019-00623-5","journal-title":"CNS Drugs"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000057","article-title":"PharmGKB summary: tramadol pathway","volume":"24","author":"Gong L","year":"2014","unstructured":"Gong L, Stamer UM, Tzvetkov MV, Altman RB, Klein TE. PharmGKB summary: tramadol pathway. Pharmacogenet Genomics. 2014, 24:374-80. 10.1097\/FPC.0000000000000057","journal-title":"Pharmacogenet Genomics"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru RR","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, et al.. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019, 27:1578-89. 10.1016\/j.joca.2019.06.011","journal-title":"Osteoarthritis Cartilage"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2012.00578.x","article-title":"A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain","volume":"13","author":"Pergolizzi JV Jr","year":"2013","unstructured":"Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract. 2013, 13:239-52. 10.1111\/j.1533-2500.2012.00578.x","journal-title":"Pain Pract"},{"key":"ref81","unstructured":"Drug Approvals and Databases.. (2015). https.\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/drug-approvals-and-databases.."},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.2165\/11539240-000000000-00000","article-title":"Duloxetine: clinical pharmacokinetics and drug interactions","volume":"50","author":"Knadler MP","year":"2011","unstructured":"Knadler MP, Lobo E, Chappell J, Bergstrom R. Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011, 50:281-94. 10.2165\/11539240-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.460","article-title":"Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis","volume":"34","author":"Osani MC","year":"2019","unstructured":"Osani MC, Bannuru RR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Korean J Intern Med. 2019, 34:966-73. 10.3904\/kjim.2018.460","journal-title":"Korean J Intern Med"},{"key":"ref84","unstructured":"Management of Osteoarthritis of the Knee (NonArthroplasty) Evidence-Based Clinical Practice Guideline.. (2021). https.\/\/www.aaos.org\/oak3cpg.."},{"key":"ref85","unstructured":"NSAIDs. Pharmacology and mechanism of action. (2022). Accessed: October 11, 2025: https:\/\/www.uptodate.cn\/contents\/nsaids-including-aspirin-pharmacology-and-mechanism-of-action\/print."},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050284","article-title":"Anti-inflammatory drugs and their mechanism of action","volume":"47","author":"Vane JR","year":"1998","unstructured":"Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res. 1998, 47:S78-87. 10.1007\/s000110050284","journal-title":"Inflamm Res"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.52965\/001c.25549","article-title":"A comprehensive review of Viscosupplementation in osteoarthritis of the knee","volume":"13","author":"Peck J","year":"2021","unstructured":"Peck J, Slovek A, Miro P, et al.. A comprehensive review of Viscosupplementation in osteoarthritis of the knee. Orthop Rev (Pavia). 2021, 13:25549. 10.52965\/001c.25549","journal-title":"Orthop Rev (Pavia)"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3390\/ph17111557","article-title":"Less pain with intra-articular hyaluronic acid injections for knee osteoarthritis compared to placebo: a systematic review and meta-analysis of randomised controlled trials","volume":"17","author":"Migliorini F","year":"2024","unstructured":"Migliorini F, Maffulli N, Sch\u00e4fer L, Kubach J, Betsch M, Pasurka M. Less pain with intra-articular hyaluronic acid injections for knee osteoarthritis compared to placebo: a systematic review and meta-analysis of randomised controlled trials. Pharmaceuticals (Basel). 2024, 17:1557. 10.3390\/ph17111557","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2023.02.006","article-title":"Different molecular weights of hyaluronan research in knee osteoarthritis: a state-of-the-art review","volume":"117","author":"Lu KH","year":"2023","unstructured":"Lu KH, Lu PW, Lin CW, Lu EW, Yang SF. Different molecular weights of hyaluronan research in knee osteoarthritis: a state-of-the-art review. Matrix Biol. 2023, 117:46-71. 10.1016\/j.matbio.2023.02.006","journal-title":"Matrix Biol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1951.03670340019005","article-title":"Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent","volume":"147","author":"Hollander JL","year":"1951","unstructured":"Hollander JL, Brown EM Jr, Jessar RA, Brown CY. Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc. 1951, 147:1629-35. 10.1001\/jama.1951.03670340019005","journal-title":"J Am Med Assoc"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.11.634","article-title":"Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how?","volume":"56","author":"Creamer P","year":"1997","unstructured":"Creamer P. Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how?. Ann Rheum Dis. 1997, 56:634-6. 10.1136\/ard.56.11.634","journal-title":"Ann Rheum Dis"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.7.603","article-title":"Molecular mechanisms of glucocorticoid action: what is important?","volume":"55","author":"Newton R","year":"2000","unstructured":"Newton R. Molecular mechanisms of glucocorticoid action: what is important?. Thorax. 2000, 55:603-13. 10.1136\/thorax.55.7.603","journal-title":"Thorax"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-200910000-00006","article-title":"The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies","volume":"17","author":"Hepper CT","year":"2009","unstructured":"Hepper CT, Halvorson JJ, Duncan ST, Gregory AJ, Dunn WR, Spindler KP. The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies. J Am Acad Orthop Surg. 2009, 17:638-46. 10.5435\/00124635-200910000-00006","journal-title":"J Am Acad Orthop Surg"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.03.010","article-title":"Intra-articular targeting of nanomaterials for the treatment of osteoarthritis","volume":"93","author":"Brown S","year":"2019","unstructured":"Brown S, Kumar S, Sharma B. Intra-articular targeting of nanomaterials for the treatment of osteoarthritis. Acta Biomater. 2019, 93:239-57. 10.1016\/j.actbio.2019.03.010","journal-title":"Acta Biomater"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1135-x","article-title":"Systemic effects of intra-articular corticosteroids","volume":"28","author":"Habib GS","year":"2009","unstructured":"Habib GS. Systemic effects of intra-articular corticosteroids. Clin Rheumatol. 2009, 28:749-56. 10.1007\/s10067-009-1135-x","journal-title":"Clin Rheumatol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01083-3","article-title":"Triamcinolone acetonide extended-release: a review in osteoarthritis pain of the knee","volume":"79","author":"Paik J","year":"2019","unstructured":"Paik J, Duggan ST, Keam SJ. Triamcinolone acetonide extended-release: a review in osteoarthritis pain of the knee. Drugs. 2019, 79:455-62. 10.1007\/s40265-019-01083-3","journal-title":"Drugs"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2020.09.022","article-title":"Common practices in intra-articular corticosteroid injection for the treatment of knee osteoarthritis: a survey of the American Association of Hip and Knee Surgeons membership","volume":"36","author":"Blankstein M","year":"2021","unstructured":"Blankstein M, Lentine B, Nelms NJ. Common practices in intra-articular corticosteroid injection for the treatment of knee osteoarthritis: a survey of the American Association of Hip and Knee Surgeons membership. J Arthroplasty. 2021, 36:845-50. 10.1016\/j.arth.2020.09.022","journal-title":"J Arthroplasty"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0311668","article-title":"Intra-articular corticosteroid injections for osteoarthritis: a qualitative study of patients' and clinicians' experiences","volume":"19","author":"Moore AJ","year":"2024","unstructured":"Moore AJ, Palmer CK, Barker KL, Gooberman-Hill R, Judge A, Wylde V, Whitehouse MR. Intra-articular corticosteroid injections for osteoarthritis: a qualitative study of patients' and clinicians' experiences. PLoS One. 2024, 19:e0311668. 10.1371\/journal.pone.0311668","journal-title":"PLoS One"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S154002","article-title":"Knee osteoarthritis: pathophysiology and current treatment modalities","volume":"11","author":"Mora JC","year":"2018","unstructured":"Mora JC, Przkora R, Cruz-Almeida Y. Knee osteoarthritis: pathophysiology and current treatment modalities. J Pain Res. 2018, 11:2189-96. 10.2147\/JPR.S154002","journal-title":"J Pain Res"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.04.010","article-title":"Where and how to inject the knee-a systematic review","volume":"43","author":"Maricar N","year":"2013","unstructured":"Maricar N, Parkes MJ, Callaghan MJ, Felson DT, O'Neill TW. Where and how to inject the knee-a systematic review. Semin Arthritis Rheum. 2013, 43:195-203. 10.1016\/j.semarthrit.2013.04.010","journal-title":"Semin Arthritis Rheum"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1177\/2325967118756576","article-title":"Existing evidence on ultrasound-guided injections in sports medicine","volume":"6","author":"Daniels EW","year":"2018","unstructured":"Daniels EW, Cole D, Jacobs B, Phillips SF. Existing evidence on ultrasound-guided injections in sports medicine. Orthop J Sports Med. 2018, 6:2325967118756576. 10.1177\/2325967118756576","journal-title":"Orthop J Sports Med"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1215534","article-title":"Viscosupplementation for osteoarthritis of the knee","volume":"372","author":"Hunter DJ","year":"2015","unstructured":"Hunter DJ. Viscosupplementation for osteoarthritis of the knee. N Engl J Med. 2015, 372:1040-7. 10.1056\/NEJMct1215534","journal-title":"N Engl J Med"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-014-0205-0","article-title":"Pharmacology of intra-articular triamcinolone","volume":"22","author":"Scherer J","year":"2014","unstructured":"Scherer J, Rainsford KD, Kean CA, Kean WF. Pharmacology of intra-articular triamcinolone. Inflammopharmacology. 2014, 22:201-17. 10.1007\/s10787-014-0205-0","journal-title":"Inflammopharmacology"},{"key":"ref104","article-title":"Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada","volume":"23","author":"Lussier A","year":"1996","unstructured":"Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De M\u00e9dicis R. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol. 1996, 23:1579-85.","journal-title":"J Rheumatol"},{"key":"ref105","article-title":"Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases","volume":"84","author":"Chen AL","year":"2002","unstructured":"Chen AL, Desai P, Adler EM, Di Cesare PE. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases. J Bone Joint Surg Am. 2002, 84:1142-7.","journal-title":"J Bone Joint Surg Am"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-017-0180-3","article-title":"Recent advances in hyaluronic acid based therapy for osteoarthritis","volume":"7","author":"Bowman S","year":"2018","unstructured":"Bowman S, Awad ME, Hamrick MW, Hunter M, Fulzele S. Recent advances in hyaluronic acid based therapy for osteoarthritis. Clin Transl Med. 2018, 7:6. 10.1186\/s40169-017-0180-3","journal-title":"Clin Transl Med"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-019-2525-0","article-title":"Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee","volume":"20","author":"Charlesworth J","year":"2019","unstructured":"Charlesworth J, Fitzpatrick J, Perera NK, Orchard J. Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee. BMC Musculoskelet Disord. 2019, 20:151. 10.1186\/s12891-019-2525-0","journal-title":"BMC Musculoskelet Disord"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2019.1584329","article-title":"Low frequency of septic arthritis after arthrocentesis and intra-articular glucocorticoid injection","volume":"48","author":"Petersen SK","year":"2019","unstructured":"Petersen SK, Hansen I, Andreasen RA. Low frequency of septic arthritis after arthrocentesis and intra-articular glucocorticoid injection. Scand J Rheumatol. 2019, 48:393-7. 10.1080\/03009742.2019.1584329","journal-title":"Scand J Rheumatol"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5283","article-title":"Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial","volume":"317","author":"McAlindon TE","year":"2017","unstructured":"McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, Ward RJ. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017, 317:1967-75. 10.1001\/jama.2017.5283","journal-title":"JAMA"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1177\/2325967115581163","article-title":"The effect of intra-articular corticosteroids on articular cartilage: a systematic review","volume":"3","author":"Wernecke C","year":"2015","unstructured":"Wernecke C, Braun HJ, Dragoo JL. The effect of intra-articular corticosteroids on articular cartilage: a systematic review. Orthop J Sports Med. 2015, 3:2325967115581163. 10.1177\/2325967115581163","journal-title":"Orthop J Sports Med"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.62848\/bjpain.v3i2.5658","article-title":"Experience of avascular necrosis of hip joint due to unjustified use of steroid: a case series study","volume":"3","author":"Hossain MM","year":"2023","unstructured":"Hossain MM, Kamal MM, Akter E, Bhuiyan MR, Zunaid M, Akhtaruzzaman AK. Experience of avascular necrosis of hip joint due to unjustified use of steroid: a case series study. Bangladesh Journal of Pain. 2023, 3:42-7. 10.62848\/bjpain.v3i2.5658","journal-title":"Bangladesh Journal of Pain"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2019.1691997","article-title":"Pharmacodynamics, efficacy, safety and administration of intra-articular therapies for knee osteoarthritis","volume":"15","author":"Oo WM","year":"2019","unstructured":"Oo WM, Liu X, Hunter DJ. Pharmacodynamics, efficacy, safety and administration of intra-articular therapies for knee osteoarthritis. Expert Opin Drug Metab Toxicol. 2019, 15:1021-32. 10.1080\/17425255.2019.1691997","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-019-02996-x","article-title":"The use of PRP injections in the management of knee osteoarthritis","volume":"376","author":"O'Connell B","year":"2019","unstructured":"O'Connell B, Wragg NM, Wilson SL. The use of PRP injections in the management of knee osteoarthritis. Cell Tissue Res. 2019, 376:143-52. 10.1007\/s00441-019-02996-x","journal-title":"Cell Tissue Res"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1177\/0363546514541540","article-title":"Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial","volume":"42","author":"A Hamid MS","year":"2014","unstructured":"A Hamid MS, Mohamed Ali MR, Yusof A, George J, Lee LP. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. Am J Sports Med. 2014, 42:2410-18. 10.1177\/0363546514541540","journal-title":"Am J Sports Med"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2005.08.016","article-title":"The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells","volume":"101","author":"Ogino Y","year":"2006","unstructured":"Ogino Y, Ayukawa Y, Kukita T, Koyano K. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006, 101:724-9. 10.1016\/j.tripleo.2005.08.016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1177\/1947603520931170","article-title":"PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials","volume":"13","author":"Filardo G","year":"2021","unstructured":"Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A. PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Cartilage. 2021, 13:364S-75S. 10.1177\/1947603520931170","journal-title":"Cartilage"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1177\/03635465241283463","article-title":"Influence of platelet concentration on the clinical outcome of platelet-rich plasma injections in knee osteoarthritis","volume":"52","author":"Boffa A","year":"2024","unstructured":"Boffa A, De Marziani L, Andriolo L, Di Martino A, Romandini I, Zaffagnini S, Filardo G. Influence of platelet concentration on the clinical outcome of platelet-rich plasma injections in knee osteoarthritis. Am J Sports Med. 2024, 52:3223-31. 10.1177\/03635465241283463","journal-title":"Am J Sports Med"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jisako.2023.07.010","article-title":"Review of Dohan Eherenfest et\u00a0al. (2009) on \"Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)\"","volume":"9","author":"Mar\u00edn Ferm\u00edn T","year":"2024","unstructured":"Mar\u00edn Ferm\u00edn T, Calcei JG, Della Vedova F, et al.. Review of Dohan Eherenfest et\u00a0al. (2009) on \"Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)\". J ISAKOS. 2024, 9:215-20. 10.1016\/j.jisako.2023.07.010","journal-title":"J ISAKOS"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2012.04.148","article-title":"Platelet-rich plasma: the PAW classification system","volume":"28","author":"DeLong JM","year":"2012","unstructured":"DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012, 28:998-1009. 10.1016\/j.arthro.2012.04.148","journal-title":"Arthroscopy"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1177\/0363546514525593","article-title":"The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy","volume":"42","author":"Braun HJ","year":"2014","unstructured":"Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med. 2014, 42:1204-10. 10.1177\/0363546514525593","journal-title":"Am J Sports Med"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1177\/1947603518756462","article-title":"Treating severe knee osteoarthritis with combination of intra-osseous and intra-articular infiltrations of platelet-rich plasma: an observational study","volume":"10","author":"S\u00e1nchez M","year":"2019","unstructured":"S\u00e1nchez M, Delgado D, Pompei O, et al.. Treating severe knee osteoarthritis with combination of intra-osseous and intra-articular infiltrations of platelet-rich plasma: an observational study. Cartilage. 2019, 10:245-53. 10.1177\/1947603518756462","journal-title":"Cartilage"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1677792","article-title":"Are subchondral intraosseous injections effective and safe for the treatment of knee osteoarthritis? A systematic review","volume":"32","author":"Sundaram K","year":"2019","unstructured":"Sundaram K, Vargas-Hern\u00e1ndez JS, Sanchez TR, Moreu NM, Mont MA, Higuera CA, Piuzzi NS. Are subchondral intraosseous injections effective and safe for the treatment of knee osteoarthritis? A systematic review. J Knee Surg. 2019, 32:1046-57. 10.1055\/s-0039-1677792","journal-title":"J Knee Surg"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2024.07.004","article-title":"Adverse events related to platelet-rich plasma therapy and future issues to be resolved","volume":"26","author":"Arita A","year":"2024","unstructured":"Arita A, Tobita M. Adverse events related to platelet-rich plasma therapy and future issues to be resolved. Regen Ther. 2024, 26:496-501. 10.1016\/j.reth.2024.07.004","journal-title":"Regen Ther"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-019-00490-6","article-title":"Medicinal signalling cells: they work, so use them","volume":"566","author":"Caplan AI","year":"2019","unstructured":"Caplan AI. Medicinal signalling cells: they work, so use them. Nature. 2019, 566:39. 10.1038\/d41586-019-00490-6","journal-title":"Nature"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.5792\/ksrr.17.201","article-title":"Intra-articular injection of bone marrow-derived mesenchymal stem cells leading to better clinical outcomes without difference in MRI outcomes from baseline in patients with knee osteoarthritis","volume":"30","author":"Shin YS","year":"2018","unstructured":"Shin YS, Yoon JR, Kim HS, Lee SH. Intra-articular injection of bone marrow-derived mesenchymal stem cells leading to better clinical outcomes without difference in MRI outcomes from baseline in patients with knee osteoarthritis. Knee Surg Relat Res. 2018, 30:206-14. 10.5792\/ksrr.17.201","journal-title":"Knee Surg Relat Res"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-019-03267-8","article-title":"Improved outcomes after mesenchymal stem cells injections for knee osteoarthritis: results at 12-months follow-up: a systematic review of the literature","volume":"140","author":"Migliorini F","year":"2020","unstructured":"Migliorini F, Rath B, Colarossi G, Driessen A, Tingart M, Niewiera M, Eschweiler J. Improved outcomes after mesenchymal stem cells injections for knee osteoarthritis: results at 12-months follow-up: a systematic review of the literature. Arch Orthop Trauma Surg. 2020, 140:853-68. 10.1007\/s00402-019-03267-8","journal-title":"Arch Orthop Trauma Surg"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger MF","year":"2019","unstructured":"Pittenger MF, Discher DE, P\u00e9ault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019, 4:22. 10.1038\/s41536-019-0083-6","journal-title":"NPJ Regen Med"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2014-0291","article-title":"Body management: mesenchymal stem cells control the internal regenerator","volume":"4","author":"Caplan AI","year":"2015","unstructured":"Caplan AI, Hariri R. Body management: mesenchymal stem cells control the internal regenerator. Stem Cells Transl Med. 2015, 4:695-701. 10.5966\/sctm.2014-0291","journal-title":"Stem Cells Transl Med"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2018.07.028","article-title":"Intra-articular mesenchymal stem cells in osteoarthritis of the knee: a systematic review of clinical outcomes and evidence of cartilage repair","volume":"35","author":"Ha CW","year":"2019","unstructured":"Ha CW, Park YB, Kim SH, Lee HJ. Intra-articular mesenchymal stem cells in osteoarthritis of the knee: a systematic review of clinical outcomes and evidence of cartilage repair. Arthroscopy. 2019, 35:277-88.e2. 10.1016\/j.arthro.2018.07.028","journal-title":"Arthroscopy"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2020-103671","article-title":"Autologous stem cell therapy in knee osteoarthritis: a systematic review of randomised controlled trials","volume":"55","author":"Wiggers TG","year":"2021","unstructured":"Wiggers TG, Winters M, Van den Boom NA, Haisma HJ, Moen MH. Autologous stem cell therapy in knee osteoarthritis: a systematic review of randomised controlled trials. Br J Sports Med. 2021, 55:1161-9. 10.1136\/bjsports-2020-103671","journal-title":"Br J Sports Med"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-018-5118-9","article-title":"Injective mesenchymal stem cell-based treatments for knee osteoarthritis: from mechanisms of action to current clinical evidences","volume":"27","author":"Lopa S","year":"2019","unstructured":"Lopa S, Colombini A, Moretti M, de Girolamo L. Injective mesenchymal stem cell-based treatments for knee osteoarthritis: from mechanisms of action to current clinical evidences. Knee Surg Sports Traumatol Arthrosc. 2019, 27:2003-20. 10.1007\/s00167-018-5118-9","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.2217\/rme-2023-0014","article-title":"Derivation of a clinical decision rule for a bone marrow aspirate concentrate injection in knee osteoarthritis","volume":"18","author":"Smith AD","year":"2023","unstructured":"Smith AD, Sydora D, Burnham R. Derivation of a clinical decision rule for a bone marrow aspirate concentrate injection in knee osteoarthritis. Regen Med. 2023, 18:461-70. 10.2217\/rme-2023-0014","journal-title":"Regen Med"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0170OC","article-title":"Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer","volume":"196","author":"Morrison TJ","year":"2017","unstructured":"Morrison TJ, Jackson MV, Cunningham EK, Kissenpfennig A, McAuley DF, O'Kane CM, Krasnodembskaya AD. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med. 2017, 196:1275-86. 10.1164\/rccm.201701-0170OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2019.10.012","article-title":"Extracellular vesicles: Potential role in osteoarthritis regenerative medicine","volume":"21","author":"Wu X","year":"2020","unstructured":"Wu X, Wang Y, Xiao Y, Crawford R, Mao X, Prasadam I. Extracellular vesicles: Potential role in osteoarthritis regenerative medicine. J Orthop Translat. 2020, 21:73-80. 10.1016\/j.jot.2019.10.012","journal-title":"J Orthop Translat"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-16465-2_29","article-title":"The future of cartilage repair.","author":"Hudetz D","year":"2019","unstructured":"Hudetz D, Jele\u010d \u017d, Rod E, et al.. The future of cartilage repair. . Personalized Medicine in Healthcare Systems: Legal, Medical and Economic Implications. Bodiroga-Vukobrat N, Rukavina D, Paveli\u0107 K, Sander GG (ed): Springer, Cham; 2019. 375-411. 10.1007\/978-3-030-16465-2_29"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.3390\/genes10060474","article-title":"Immunophenotyping of a stromal vascular fraction from Microfragmented lipoaspirate used in osteoarthritis cartilage treatment and its lipoaspirate counterpart","volume":"10","author":"Polancec D","year":"2019","unstructured":"Polancec D, Zenic L, Hudetz D, et al.. Immunophenotyping of a stromal vascular fraction from Microfragmented lipoaspirate used in osteoarthritis cartilage treatment and its lipoaspirate counterpart. Genes (Basel). 2019, 10:474. 10.3390\/genes10060474","journal-title":"Genes (Basel)"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002214","article-title":"A brief review of current treatment options for osteoarthritis including disease-modifying osteoarthritis drugs (DMOADs) and novel therapeutics","volume":"86","author":"Jiang P","year":"2024","unstructured":"Jiang P, Hu K, Jin L, Luo Z. A brief review of current treatment options for osteoarthritis including disease-modifying osteoarthritis drugs (DMOADs) and novel therapeutics. Ann Med Surg (Lond). 2024, 86:4042-8. 10.1097\/MS9.0000000000002214","journal-title":"Ann Med Surg (Lond)"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2014.03.004","article-title":"The hallmarks of osteoarthritis and the potential to develop personalised disease-modifying pharmacological therapeutics","volume":"22","author":"Tonge DP","year":"2014","unstructured":"Tonge DP, Pearson MJ, Jones SW. The hallmarks of osteoarthritis and the potential to develop personalised disease-modifying pharmacological therapeutics. Osteoarthritis Cartilage. 2014, 22:609-21. 10.1016\/j.joca.2014.03.004","journal-title":"Osteoarthritis Cartilage"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57425-9","article-title":"POU domain motif3 (Pdm3) induces wingless (wg) transcription and is essential for development of larval neuromuscular junctions in Drosophila","volume":"10","author":"Kim Y","year":"2020","unstructured":"Kim Y, Cho KO. POU domain motif3 (Pdm3) induces wingless (wg) transcription and is essential for development of larval neuromuscular junctions in Drosophila. Sci Rep. 2020, 10:517. 10.1038\/s41598-020-57425-9","journal-title":"Sci Rep"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96308","article-title":"Inhibition of Wnt\/\u03b2-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis","volume":"3","author":"Lietman C","year":"2018","unstructured":"Lietman C, Wu B, Lechner S, et al.. Inhibition of Wnt\/\u03b2-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis. JCI Insight. 2018, 3:e96308. 10.1172\/jci.insight.96308","journal-title":"JCI Insight"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02059-9","article-title":"Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial","volume":"28","author":"Gerwin N","year":"2022","unstructured":"Gerwin N, Scotti C, Halleux C, et al.. Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial. Nat Med. 2022, 28:2633-45. 10.1038\/s41591-022-02059-9","journal-title":"Nat Med"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170513","article-title":"Mocetinostat activates Kr\u00fcppel-like factor 4 and protects against tissue destruction and inflammation in osteoarthritis","volume":"8","author":"Kawata M","year":"2023","unstructured":"Kawata M, McClatchy DB, Diedrich JK, Olmer M, Johnson KA, Yates JR, Lotz MK. Mocetinostat activates Kr\u00fcppel-like factor 4 and protects against tissue destruction and inflammation in osteoarthritis. JCI Insight. 2023, 8:10.1172\/jci.insight.170513","journal-title":"JCI Insight"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac467","article-title":"Metformin attenuates osteoarthritis by targeting chondrocytes, synovial macrophages and adipocytes","volume":"62","author":"Li D","year":"2023","unstructured":"Li D, Ruan G, Zhang Y, et al.. Metformin attenuates osteoarthritis by targeting chondrocytes, synovial macrophages and adipocytes. Rheumatology (Oxford). 2023, 62:1652-61. 10.1093\/rheumatology\/keac467","journal-title":"Rheumatology (Oxford)"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.07.034","article-title":"Tofacitinib and TPCA-1 exert chondroprotective effects on extracellular matrix turnover in bovine articular cartilage ex vivo","volume":"165","author":"Kjelgaard-Petersen CF","year":"2019","unstructured":"Kjelgaard-Petersen CF, Sharma N, Kayed A, et al.. Tofacitinib and TPCA-1 exert chondroprotective effects on extracellular matrix turnover in bovine articular cartilage ex vivo. Biochem Pharmacol. 2019, 165:91-8. 10.1016\/j.bcp.2018.07.034","journal-title":"Biochem Pharmacol"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.09.018","article-title":"Subchondral bone as a key target for osteoarthritis treatment","volume":"83","author":"Casta\u00f1eda S","year":"2012","unstructured":"Casta\u00f1eda S, Roman-Blas JA, Largo R, Herrero-Beaumont G. Subchondral bone as a key target for osteoarthritis treatment. Biochem Pharmacol. 2012, 83:315-23. 10.1016\/j.bcp.2011.09.018","journal-title":"Biochem Pharmacol"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271485","article-title":"Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorption","volume":"17","author":"Ding D","year":"2022","unstructured":"Ding D, Wang L, Yan J, et al.. Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorption. PLoS One. 2022, 17:e0271485. 10.1371\/journal.pone.0271485","journal-title":"PLoS One"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"Berenbaum F","year":"2013","unstructured":"Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013, 21:16-21. 10.1016\/j.joca.2012.11.012","journal-title":"Osteoarthritis Cartilage"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2023.12.003","article-title":"Genicular artery embolization for knee osteoarthritis: results of the LipioJoint-1 trial","volume":"105","author":"Sapoval M","year":"2024","unstructured":"Sapoval M, Querub C, Pereira H, et al.. Genicular artery embolization for knee osteoarthritis: results of the LipioJoint-1 trial. Diagn Interv Imaging. 2024, 105:144-50. 10.1016\/j.diii.2023.12.003","journal-title":"Diagn Interv Imaging"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2013.02.033","article-title":"Transcatheter arterial embolization using imipenem\/cilastatin sodium for tendinopathy and enthesopathy refractory to nonsurgical management","volume":"24","author":"Okuno Y","year":"2013","unstructured":"Okuno Y, Matsumura N, Oguro S. Transcatheter arterial embolization using imipenem\/cilastatin sodium for tendinopathy and enthesopathy refractory to nonsurgical management. J Vasc Interv Radiol. 2013, 24:787-92. 10.1016\/j.jvir.2013.02.033","journal-title":"J Vasc Interv Radiol"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1002\/osp4.762","article-title":"Impact of semaglutide on osteoarthritis risk in patients with obesity: a retrospective cohort study","volume":"10","author":"Baser O","year":"2024","unstructured":"Baser O, Isenman L, Baser S. Impact of semaglutide on osteoarthritis risk in patients with obesity: a retrospective cohort study. Obes Sci Prac. 2024, 10:e762. 10.1002\/osp4.762","journal-title":"Obes Sci Prac"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.10.007","article-title":"Osteoarthritis: Pathology, diagnosis, and treatment options","volume":"104","author":"Abramoff B","year":"2020","unstructured":"Abramoff B, Caldera FE. Osteoarthritis: Pathology, diagnosis, and treatment options. Med Clin North Am. 2020, 104:293-311. 10.1016\/j.mcna.2019.10.007","journal-title":"Med Clin North Am"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.4103\/CJP.CJP_11_19","article-title":"Fibroblast growth factors: Potential novel targets for regenerative therapy of osteoarthritis","volume":"62","author":"Chen TM","year":"2019","unstructured":"Chen TM, Chen YH, Sun HS, Tsai SJ. Fibroblast growth factors: Potential novel targets for regenerative therapy of osteoarthritis. Chin J Physiol. 2019, 62:2-10. 10.4103\/CJP.CJP_11_19","journal-title":"Chin J Physiol"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9471","article-title":"Microsatellite in the 3' untranslated region of human fibroblast growth factor 9 (FGF9) gene exhibits pleiotropic effect on modulating FGF9 protein expression","volume":"28","author":"Chen TM","year":"2007","unstructured":"Chen TM, Kuo PL, Hsu CH, Tsai SJ, Chen MJ, Lin CW, Sun HS. Microsatellite in the 3' untranslated region of human fibroblast growth factor 9 (FGF9) gene exhibits pleiotropic effect on modulating FGF9 protein expression. Hum Mutat. 2007, 28:98. 10.1002\/humu.9471","journal-title":"Hum Mutat"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.22203\/eCM.v038a03","article-title":"Recombinant human FGF18 preserves depth-dependent mechanical inhomogeneity in articular cartilage","volume":"38","author":"Meloni GR","year":"2019","unstructured":"Meloni GR, Farran A, Mohanraj B, et al.. Recombinant human FGF18 preserves depth-dependent mechanical inhomogeneity in articular cartilage. Eur Cell Mater. 2019, 38:23-34. 10.22203\/eCM.v038a03","journal-title":"Eur Cell Mater"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216453","article-title":"Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial","volume":"79","author":"Eckstein F","year":"2020","unstructured":"Eckstein F, Kraines JL, Aydemir A, Wirth W, Maschek S, Hochberg MC. Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial. Ann Rheum Dis. 2020, 79:525-8. 10.1136\/annrheumdis-2019-216453","journal-title":"Ann Rheum Dis"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2014.11.013","article-title":"Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation","volume":"23","author":"Correa D","year":"2015","unstructured":"Correa D, Somoza RA, Lin P, et al.. Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation. Osteoarthritis Cartilage. 2015, 23:443-53. 10.1016\/j.joca.2014.11.013","journal-title":"Osteoarthritis Cartilage"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2006.09.001","article-title":"Bone morphogenetic protein 7 (bmp-7) stimulates proteoglycan synthesis in human osteoarthritic chondrocytes in vitro","volume":"60","author":"St\u00f6ve J","year":"2006","unstructured":"St\u00f6ve J, Schneider-Wald B, Scharf HP, Schwarz ML. Bone morphogenetic protein 7 (bmp-7) stimulates proteoglycan synthesis in human osteoarthritic chondrocytes in vitro. Biomed Pharmacother. 2006, 60:639-43. 10.1016\/j.biopha.2006.09.001","journal-title":"Biomed Pharmacother"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2009.10.009","article-title":"Bone morphogenetic protein signaling and arthritis","volume":"20","author":"Lories RJ","year":"2009","unstructured":"Lories RJ, Luyten FP. Bone morphogenetic protein signaling and arthritis. Cytokine Growth Factor Rev. 2009, 20:467-73. 10.1016\/j.cytogfr.2009.10.009","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-11-232","article-title":"Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis","volume":"11","author":"Hunter DJ","year":"2010","unstructured":"Hunter DJ, Pike MC, Jonas BL, Kissin E, Krop J, McAlindon T. Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskelet Disord. 2010, 11:232. 10.1186\/1471-2474-11-232","journal-title":"BMC Musculoskelet Disord"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2018.03.008","article-title":"Blockade of vascular endothelial growth factor receptor-1 (Flt-1), reveals a novel analgesic for osteoarthritis-induced joint pain","volume":"11","author":"Das V","year":"2018","unstructured":"Das V, Kc R, Li X, et al.. Blockade of vascular endothelial growth factor receptor-1 (Flt-1), reveals a novel analgesic for osteoarthritis-induced joint pain. Gene Rep. 2018, 11:94-100. 10.1016\/j.genrep.2018.03.008","journal-title":"Gene Rep"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2018.1547706","article-title":"Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics","volume":"23","author":"Oo WM","year":"2018","unstructured":"Oo WM, Yu SP, Daniel MS, Hunter DJ. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics. Expert Opin Emerg Drugs. 2018, 23:331-47. 10.1080\/14728214.2018.1547706","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02759-0","article-title":"Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study","volume":"24","author":"Neogi T","year":"2022","unstructured":"Neogi T, Hunter DJ, Churchill M, et al.. Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study. Arthritis Res Ther. 2022, 24:78. 10.1186\/s13075-022-02759-0","journal-title":"Arthritis Res Ther"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105739","article-title":"New therapeutic strategies in osteoarthritis","volume":"91","author":"Siddiq MA","year":"2024","unstructured":"Siddiq MA, Oo WM, Hunter DJ. New therapeutic strategies in osteoarthritis. Joint Bone Spine. 2024, 91:105739. 10.1016\/j.jbspin.2024.105739","journal-title":"Joint Bone Spine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419630-knee-osteoarthritis-current-insights-into-pathophysiology-and-non-surgical-management-options","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:03:56Z","timestamp":1761303836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419630-knee-osteoarthritis-current-insights-into-pathophysiology-and-non-surgical-management-options"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":163,"URL":"https:\/\/doi.org\/10.7759\/cureus.95302","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}